Infectious Disease (ID) learning unit: What the ID clinician needs to know about buprenorphine treatment for opioid use disorder

4Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the context of an escalating opioid epidemic, infectious disease clinicians increasingly treat the infectious complications of injection drug use. In this learning unit, we review the history, pharmacology, and clinical use of buprenorphine as maintenance therapy for opioid use disorder, and we describe the process by which clinicians can obtain a buprenorphine waiver.

Cite

CITATION STYLE

APA

Westlake, A. A., & Eisenberg, M. P. (2017). Infectious Disease (ID) learning unit: What the ID clinician needs to know about buprenorphine treatment for opioid use disorder. Open Forum Infectious Diseases, 4(1). https://doi.org/10.1093/ofid/ofw251

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free